6 insiders reported 35 Form 4 transactions for RenovoRx, Inc. (RNXT) over the past 18 months (most recent 2026-06-24). Recent activity: RYAN UNA S (Director) Buy 47,789 shares, RYAN UNA S (Director) Buy 6,332 shares, RYAN UNA S (Director) Buy 26,838 shares, RYAN UNA S (Director) Buy 16,206 shares, VOLL MARK (Chief Financial Officer) Buy 25,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-24 | RYAN UNA S | Director | Buy | 47,789 | $200,236 |
| 2026-06-24 | RYAN UNA S | Director | Buy | 6,332 | $25,011 |
| 2026-06-24 | RYAN UNA S | Director | Buy | 26,838 | $25,000 |
| 2026-06-24 | RYAN UNA S | Director | Buy | 16,206 | $26,278 |
| 2026-05-21 | VOLL MARK | Chief Financial Officer | Buy | 25,000 | $19,690 |
| 2026-04-07 | VOLL MARK | Chief Financial Officer | Buy | 80,000 | $0 |
| 2026-03-27 | VOLL MARK | Chief Financial Officer | Buy | 12,380 | $0 |
| 2026-03-24 | VOLL MARK | Chief Financial Officer | Buy | 97,200 | $0 |
| 2026-03-24 | Marton Laurence | Director | Buy | 9,720 | $0 |
| 2026-03-24 | Bagai Shaun | Chief Executive Officer | Buy | 24,300 | $0 |
| 2026-01-22 | Agah Ramtin | Chief Medical Officer | Buy | 10,000 | $10,000 |
| 2026-01-05 | Agah Ramtin | Chief Medical Officer | Buy | 9,795 | $8,424 |
| 2026-01-02 | Agah Ramtin | Chief Medical Officer | Buy | 205 | $170 |
| 2025-12-22 | Bagai Shaun | Chief Executive Officer | Buy | 5,000 | $4,500 |
| 2025-12-19 | Bagai Shaun | Chief Executive Officer | Buy | 5,000 | $4,250 |
| 2025-12-17 | Agah Ramtin | Chief Medical Officer | Buy | 12,000 | $10,200 |
| 2025-12-08 | Agah Ramtin | Chief Medical Officer | Buy | 10,000 | $9,600 |
| 2025-11-24 | Agah Ramtin | Chief Medical Officer | Buy | 10,000 | $8,000 |
| 2025-11-24 | Agah Ramtin | Chief Medical Officer | Buy | 12,000 | $9,600 |
| 2025-08-26 | Bagai Shaun | Chief Executive Officer | Buy | 5,000 | $4,750 |
| 2025-08-26 | Bagai Shaun | Chief Executive Officer | Buy | 5,000 | $4,550 |
| 2025-06-09 | Agah Ramtin | Chief Medical Officer | Buy | 21,000 | $29,400 |
| 2025-06-06 | Agah Ramtin | Chief Medical Officer | Sell | 400,000 | $0 |
| 2025-05-06 | Marton Laurence | Director | Buy | 20,480 | $3,072 |
| 2025-04-17 | Agah Ramtin | Chief Medical Officer | Buy | 15,000 | $13,500 |
Source: SEC Form 4 filings · as of 2026-06-24